Literature DB >> 8592960

Choosing between predictors of fractures.

S L Hui1, C W Slemenda, M A Carey, C C Johnston.   

Abstract

The identification of those at highest risk of osteoporotic fractures is a clinical goal that requires appropriate statistical comparisons of potential predictors of fractures. This article provides a formal approach of comparing individual predictors (e.g., bone mass at one site vs bone mass at another), or sets of predictors (e.g., bone mass vs other risk factors), and contrasts newer methods, such as bootstrapping, to receiver-operating-characteristics (ROC) curves, which have been previously used. The advantages of the bootstrapping approach are illustrated using time-to-fracture data from a published study demonstrating the use of baseline bone mass measurements in the prediction of fractures in 521 subjects with variable lengths of follow-up, extending to 12.5 years. Bone mineral density (BMD) was shown to be significantly better than bone mineral content (BMD) in predicting fractures in free-living subjects, but not in retirement-community subjects. Bone mineral apparent density (BMAD) was also compared with BMC and BMD and shown not to improve fracture prediction in these subjects.

Entities:  

Mesh:

Year:  1995        PMID: 8592960     DOI: 10.1002/jbmr.5650101126

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  9 in total

Review 1.  Quality and performance measures in bone densitometry. Part 2: fracture risk.

Authors:  C C Glüer; Y Lu; K Engelke
Journal:  Osteoporos Int       Date:  2006-07-04       Impact factor: 4.507

2.  Contributions of bone density and structure to fracture risk assessment in men and women.

Authors:  L Joseph Melton; Thomas J Beck; Shreyasee Amin; Sundeep Khosla; Sara J Achenbach; Ann L Oberg; B Lawrence Riggs
Journal:  Osteoporos Int       Date:  2005-02-02       Impact factor: 4.507

3.  New perspectives on the definition and the management of severe osteoporosis: the patient with two or more fragility fractures.

Authors:  R Nuti; M L Brandi; G Isaia; U Tarantino; S Silvestri; S Adami
Journal:  J Endocrinol Invest       Date:  2009-10       Impact factor: 4.256

4.  Lasofoxifene: Evidence of its therapeutic value in osteoporosis.

Authors:  Luigi Gennari; Daniela Merlotti; Vincenzo De Paola; Ranuccio Nuti
Journal:  Core Evid       Date:  2010-06-15

Review 5.  Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene.

Authors:  Luigi Gennari; Daniela Merlotti; Ranuccio Nuti
Journal:  Clin Interv Aging       Date:  2010-02-02       Impact factor: 4.458

Review 6.  Selective estrogen receptor modulators for postmenopausal osteoporosis: current state of development.

Authors:  Luigi Gennari; Daniela Merlotti; Fabrizio Valleggi; Giuseppe Martini; Ranuccio Nuti
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

7.  Quantitative ultrasound predicts hip and non-spine fracture in men: the MrOS study.

Authors:  D C Bauer; S K Ewing; J A Cauley; K E Ensrud; S R Cummings; E S Orwoll
Journal:  Osteoporos Int       Date:  2007-02-02       Impact factor: 5.071

8.  Race/ethnic differences in bone mineral density in men.

Authors:  A B Araujo; T G Travison; S S Harris; M F Holick; A K Turner; J B McKinlay
Journal:  Osteoporos Int       Date:  2007-03-06       Impact factor: 5.071

9.  Bazedoxifene for the prevention of postmenopausal osteoporosis.

Authors:  Luigi Gennari; Daniela Merlotti; Vincenzo De Paola; Giuseppe Martini; Ranuccio Nuti
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.